Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is present in approximately one-third of all congestive heart failure (CHF) patients, and is a key cause of underprescription and underdosing of β-blockers, largely owing to concerns about precipitating respiratory deterioration. For these rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Yoshiaki, Asai, Kuniya, Furuse, Erito, Nakamura, Shunichi, Murai, Koji, Tsukada, Yayoi Tetsuou, Shimizu, Wataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356705/
https://www.ncbi.nlm.nih.gov/pubmed/25784798
http://dx.doi.org/10.2147/COPD.S79942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356705/
https://www.ncbi.nlm.nih.gov/pubmed/25784798
http://dx.doi.org/10.2147/COPD.S79942

Ejemplares similares